You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 6, June 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Laparoscopic Splenectomy for Immune Thrombocytopenic Purpura

Gregory Tsiotos, MD; Richard T. Schlinkert, MD

Arch Surg. 1997;132(6):642-646.


Abstract

Objective
To evaluate laparoscopic splenectomy as a treatment of immune thrombocytopenic purpura (ITP).

Design
Retrospective review of 18 patients followed up from 1 to 30 months.

Setting
Referral center using community hospital.

Patients
Consecutive series of patients undergoing laparoscopic splenectomy for ITP.

Intervention
Laparoscopic splenectomy.

Main Outcome Measure
Surgical and hematologic results.

Results
Eighteen patients underwent laparoscopic splenectomy for ITP. All procedures were completed laparoscopically. There was no perioperative mortality. Pancreatitis developed in 1 patient (6%); 17 (94%) of 18 patients responded to splenectomy. The mean platelet count increased from 29x109 to 461x109/L after laparoscopic splenectomy and stabilized at 327x109/L (mean follow-up period, 15 months). Mean (±SEM) operative blood loss was 214±52 mL, necessitating no transfusions. Mean hospital stay was 2 days (range, 1-7 days). Most patients tolerated a liquid diet the day of the operation and a solid diet the next day. Parenteral narcotic usage averaged 12.3 morphine equivalent units, and 6 patients (33%) required no parenteral analgesia. An accessory spleen was identified in 1 patient (6%). Mean (±SEM) operative time was 130±8 minutes and was significantly less in the second half of our experience (117 vs 144 minutes, P=.04).

Conclusions
Laparoscopic splenectomy is safe and effective for the management of ITP and allows rapid recovery. With increasing experience, operative times decrease. Laparoscopic splenectomy should be the treatment of choice for patients with ITP who require splenectomy.

Arch Surg. 1997;132:642-646



Author Affiliations

From Mayo Clinic, Rochester, Minn (Dr Tsiotos), and Mayo Clinic, Scottsdale, Ariz (Dr Schlinkert).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predictive Factors for Successful Laparoscopic Splenectomy in Patients With Immune Thrombocytopenic Purpura
Duperier et al.
Arch Surg 2004;139:61-66.
ABSTRACT | FULL TEXT  

Laparoscopic Splenectomy
Schlinkert and Teotia
Arch Surg 1999;134:99-103.
ABSTRACT | FULL TEXT  

Present Status of Laparoscopic Splenectomy for Hematologic Diseases: Certitudes and Unresolved Issues
Gigot et al.
SURG INNOV 1998;5:147-167.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.